Skip Navigation

Publication Detail

Title: Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.

Authors: Medeiros, Matthew; Zheng, Xinghui; Novak, Petr; Wnek, Shawn M; Chyan, Vivian; Escudero-Lourdes, Claudia; Gandolfi, A Jay

Published In Toxicology, (2012 Jan 27)

Abstract: Bladder cancer has been associated with chronic arsenic exposure. Monomethylarsonous acid [MMA(III)] is a metabolite of inorganic arsenic and has been shown to transform an immortalized urothelial cell line (UROtsa) at concentrations 20-fold less than arsenite. MMA(III) was used as a model arsenical to examine the mechanisms of arsenical-induced transformation of urothelium. A microarray analysis was performed to assess the transcriptional changes in UROtsa during the critical window of chronic 50nM MMA(III) exposure that leads to transformation at 3 months of exposure. The analysis revealed only minor changes in gene expression at 1 and 2 months of exposure, contrasting with substantial changes observed at 3 months of exposure. The gene expression changes at 3 months were analyzed showing distinct alterations in biological processes and pathways such as a response to oxidative stress, enhanced cell proliferation, anti-apoptosis, MAPK signaling, as well as inflammation. Twelve genes selected as markers of these particular biological processes were used to validate the microarray and these genes showed a time-dependent changes at 1 and 2 months of exposure, with the most substantial changes occurring at 3 months of exposure. These results indicate that there is a strong association between the acquired phenotypic changes that occur with chronic MMA(III) exposure and the observed gene expression patterns that are indicative of a malignant transformation. Although the substantial changes that occur at 3 months of exposure may be a consequence of transformation, there are common occurrences of altered biological processes between the first 2 months of exposure and the third, which may be pivotal in driving transformation.

PubMed ID: 22108045 Exiting the NIEHS site

MeSH Terms: Apoptosis Regulatory Proteins/biosynthesis; Apoptosis Regulatory Proteins/genetics; Biomarkers, Tumor/metabolism; Cell Proliferation/drug effects; Cell Transformation, Neoplastic/drug effects; Cells, Cultured; DNA Repair; Extracellular Matrix/metabolism; Gene Expression Profiling; Gene Expression/drug effects; Humans; Inflammation/chemically induced; Inflammation/metabolism; Mitogen-Activated Protein Kinases/genetics; Mitogen-Activated Protein Kinases/metabolism; Organometallic Compounds/toxicity*; Oxidative Stress/drug effects; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Signal Transduction/drug effects; Signal Transduction/genetics; Urinary Bladder Neoplasms/chemically induced; Urinary Bladder Neoplasms/metabolism; Urothelium/cytology; Urothelium/drug effects*; Urothelium/metabolism*

Back
to Top